Literature DB >> 29773649

PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C.

Shilpee Sharma1, Prabhu S Arunachalam1, Malini Menon1, Viswanath Ragupathy2, Ravi Vijaya Satya3, Joshua Jebaraj1, Shambhu Ganeshappa Aralaguppe1, Chaitra Rao1, Sreshtha Pal1, Shanmugam Saravanan4, Kailapuri G Murugavel4, Pachamuthu Balakrishnan4, Suniti Solomon4, Indira Hewlett2, Udaykumar Ranga5.   

Abstract

HIV-1 subtype C (HIV-1C) may duplicate longer amino acid stretches in the p6 Gag protein, leading to the creation of an additional Pro-Thr/Ser-Ala-Pro (PTAP) motif necessary for viral packaging. However, the biological significance of a duplication of the PTAP motif for HIV-1 replication and pathogenesis has not been experimentally validated. In a longitudinal study of two different clinical cohorts of select HIV-1 seropositive, drug-naive individuals from India, we found that 8 of 50 of these individuals harbored a mixed infection of viral strains discordant for the PTAP duplication. Conventional and next-generation sequencing of six primary viral quasispecies at multiple time points disclosed that in a mixed infection, the viral strains containing the PTAP duplication dominated the infection. The dominance of the double-PTAP viral strains over a genetically similar single-PTAP viral clone was confirmed in viral proliferation and pairwise competition assays. Of note, in the proximity ligation assay, double-PTAP Gag proteins exhibited a significantly enhanced interaction with the host protein tumor susceptibility gene 101 (Tsg101). Moreover, Tsg101 overexpression resulted in a biphasic effect on HIV-1C proliferation, an enhanced effect at low concentration and an inhibitory effect only at higher concentrations, unlike a uniformly inhibitory effect on subtype B strains. In summary, our results indicate that the duplication of the PTAP motif in the p6 Gag protein enhances the replication fitness of HIV-1C by engaging the Tsg101 host protein with a higher affinity. Our results have implications for HIV-1 pathogenesis, especially of HIV-1C.

Entities:  

Keywords:  Gag; HIV-1C; NGS; PTAP duplication; Replication advantage; human immunodeficiency virus (HIV); infectious disease; viral DNA; viral protein; viral replication

Mesh:

Substances:

Year:  2018        PMID: 29773649      PMCID: PMC6066301          DOI: 10.1074/jbc.M117.815829

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India.

Authors:  Nagadenahalli Byrareddy Siddappa; Prashanta Kumar Dash; Anita Mahadevan; Anita Desai; Narayana Jayasuryan; Vasanthapuram Ravi; Parthasarathy Satishchandra; Susarla K Shankar; Udaykumar Ranga
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

2.  The ESCRT pathway and HIV-1 budding.

Authors:  Yoshiko Usami; Sergei Popov; Elena Popova; Michio Inoue; Winfried Weissenhorn; Heinrich G Göttlinger
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

3.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.

Authors:  P S Bilodeau; J K Domsic; C M Stoltzfus
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa.

Authors:  Ujjwal Neogi; Susan Engelbrecht; Mathilda Claassen; Graeme Brendon Jacobs; Gert van Zyl; Wolfgang Preiser; Anders Sonnerborg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-10-09       Impact factor: 2.205

7.  Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site.

Authors:  Yoshiko Usami; Sergei Popov; Heinrich G Göttlinger
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

8.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

9.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

10.  PEAR: a fast and accurate Illumina Paired-End reAd mergeR.

Authors:  Jiajie Zhang; Kassian Kobert; Tomáš Flouri; Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2013-10-18       Impact factor: 6.937

View more
  7 in total

1.  CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release.

Authors:  David O Ajasin; Vasudev R Rao; Xuhong Wu; Santhamani Ramasamy; Mario Pujato; Arthur P Ruiz; Andras Fiser; Anne R Bresnick; Ganjam V Kalpana; Vinayaka R Prasad
Journal:  Elife       Date:  2019-06-07       Impact factor: 8.140

2.  HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness.

Authors:  Robert van Domselaar; Duncan T Njenda; Rohit Rao; Anders Sönnerborg; Kamalendra Singh; Ujjwal Neogi
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

3.  Genetic Analysis of the Full-Length gag Gene from the Earliest Korean Subclade B of HIV-1: An Outbreak among Korean Hemophiliacs.

Authors:  Young-Keol Cho; Jung-Eun Kim; Brian T Foley
Journal:  Viruses       Date:  2019-06-11       Impact factor: 5.048

Review 4.  Importance of Viral Late Domains in Budding and Release of Enveloped RNA Viruses.

Authors:  Lisa Welker; Jean-Christophe Paillart; Serena Bernacchi
Journal:  Viruses       Date:  2021-08-06       Impact factor: 5.048

5.  The Evolution of Regulatory Elements in the Emerging Promoter-Variant Strains of HIV-1 Subtype C.

Authors:  Disha Bhange; Nityanand Prasad; Swati Singh; Harshit Kumar Prajapati; Shesh Prakash Maurya; Bindu Parachalil Gopalan; Sowmya Nadig; Devidas Chaturbhuj; Boobalan Jayaseelan; Thongadi Ramesh Dinesha; Syed Fazil Ahamed; Navneet Singh; Anangi Brahmaiah; Kavita Mehta; Yuvrajsinh Gohil; Pachamuthu Balakrishnan; Bimal Kumar Das; Mary Dias; Raman Gangakhedkar; Sanjay Mehendale; Ramesh S Paranjape; Shanmugam Saravanan; Anita Shet; Sunil Suhas Solomon; Madhuri Thakar; Udaykumar Ranga
Journal:  Front Microbiol       Date:  2021-11-16       Impact factor: 5.640

6.  Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China.

Authors:  Zetao Cheng; Huanchang Yan; Qingmei Li; Sherimay D Ablan; Alex Kleinpeter; Eric O Freed; Hao Wu; Emmanuel Enoch Dzakah; Jianhui Zhao; Zhigang Han; Haiying Wang; Shixing Tang
Journal:  Microbiol Spectr       Date:  2022-06-21

Review 7.  The Interplay between ESCRT and Viral Factors in the Enveloped Virus Life Cycle.

Authors:  Bo Meng; Andrew M L Lever
Journal:  Viruses       Date:  2021-02-20       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.